Pfizer gets USFDA nod for biosimilar to Rituximab Medical Dialogues Bureau25 July 2019 3:29 AM GMTRuxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
Trump administration scraps key plan to reduce US drug prices Medical Dialogues Bureau12 July 2019 3:30 AM GMTThe decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the...
Elizabeth Warren asks former USFDA chief Gottlieb to QUIT Pfizer board Medical Dialogues Bureau5 July 2019 3:40 AM GMTIn a letter to Gottlieb, Warren, who is seeking the Democratic nomination for the 2020 presidential election, said "this kind of revolving door...
GSK offers concessions to address Pfizer deal concerns Farhat Nasim23 Jun 2019 3:29 AM GMTGSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
GSK eyes sale of $1.2 billion consumer health drugs; says report Medical Dialogues Bureau22 Jun 2019 3:29 AM GMTGSK is streamlining its product offering as it prepares to fold its consumer business into a joint venture with Pfizer in the second half of this...
GSK forms drug discovery alliance with University of California CRISPR researchers Medical Dialogues Bureau14 Jun 2019 6:54 AM GMTBritish drugmaker GSK said it has struck a research deal with the early pioneers of a prominent gene-editing technology at the University of...
Sanofi loses German patent case against Amgen over cholesterol drug Praluent Medical Dialogues Bureau9 Jun 2019 4:00 AM GMTIn the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that...
GSK sells 6 brands including Savlon antiseptic cream to Stada Pharma Medical Dialogues Bureau8 Jun 2019 4:30 AM GMTThe price tag for the mainly Europe-focused brand portfolio, which includes itch relief cream Eurax, antiseptic cream Savlon and Tixylix cough...
Pfizer epilepsy drug Lyrica fails in phase III trial Medical Dialogues Bureau28 May 2019 3:30 AM GMTNew Delhi: Pfizer Inc. recently announced that a Phase 3 study to assess the use of LYRICA (pregabalin) as adjunctive therapy for epilepsy patients 5...
Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report Meghna A Singhania26 May 2019 12:43 PM GMTShanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
GSK, Pfizer gets CCI approval for consumer healthcare JV formation Garima25 May 2019 4:15 AM GMTAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
Pfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patients Farhat Nasim19 May 2019 4:15 AM GMTThe efficacy of Fragmin in children was based on a single trial with 38 pediatric patients with symptomatic deep vein thrombosis and/or pulmonary...